Comparison of the Microarray-Based Assay, the Real-Time PCR Assay, and the Bidirectional Sequencing Method for CYP2C19 Genotyping
- PMID:26427158
- DOI: 10.7754/clin.lab.2015.141214
Comparison of the Microarray-Based Assay, the Real-Time PCR Assay, and the Bidirectional Sequencing Method for CYP2C19 Genotyping
Abstract
Background: Cytochrome P450 2C19 (CYP2C19) is a clinically important enzyme that metabolizes a wide variety of drugs. Recently, some new genetic assays designed to identify the CYP2C19 genotype were introduced.
Methods: We compared the abilities of the microarray-based Verigene CYP2C19 Test (Nanosphere, USA) and the AccuPower Real-time PCR CYP (*2,*3,*17) assay (Bioneer, Korea) with the ability of the bidirectional sequencing method for the detection of CYP2C19 genotypes in 78 whole blood samples.
Results: Among 78 specimens, 28 were *1/*1, 1 was *1/*17, 27 were *1/*2, 10 were *1/*3, 8 were *2/*2, 1 was *3/*3, and 3 were *2/*3. In the initial test, five samples (6.4%) in the Verigene assay and two samples (2.4%) in the AccuPower assay failed to generate definite results. All retests with both assays generated definitive results. In both assays, the results of CYP2C19 genotyping showed 100% final concordance with those obtained by the direct sequencing method.
Conclusions: These two assays could be useful for the identification of CYP2C19 genotypes in clinical laboratories.
Similar articles
- Flow cytometric assay for genotyping cytochrome p450 2C9 and 2C19: comparison with a microelectronic DNA array.Pickering JW, McMillin GA, Gedge F, Hill HR, Lyon E.Pickering JW, et al.Am J Pharmacogenomics. 2004;4(3):199-207. doi: 10.2165/00129785-200404030-00007.Am J Pharmacogenomics. 2004.PMID:15174901
- Development of a Polymerase Chain Reaction/Ligase Detection Reaction Assay for Detection of CYP2C19 Polymorphisms.Zhang J, Zhang H, Li K, Shi M.Zhang J, et al.Genet Test Mol Biomarkers. 2018 Jan;22(1):62-73. doi: 10.1089/gtmb.2017.0086.Genet Test Mol Biomarkers. 2018.PMID:29345984
- Gastric Juice-Based Real-Time PCR for TailoredHelicobacter Pylori Treatment: A Practical Approach.Peng X, Song Z, He L, Lin S, Gong Y, Sun L, Zhao F, Gu Y, You Y, Zhou L, Zhang J.Peng X, et al.Int J Med Sci. 2017 May 15;14(6):595-601. doi: 10.7150/ijms.18996. eCollection 2017.Int J Med Sci. 2017.PMID:28638276Free PMC article.
- The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.de Leon J, Susce MT, Murray-Carmichael E.de Leon J, et al.Mol Diagn Ther. 2006;10(3):135-51. doi: 10.1007/BF03256453.Mol Diagn Ther. 2006.PMID:16771600Review.
- Clinical significance of the cytochrome P450 2C19 genetic polymorphism.Desta Z, Zhao X, Shin JG, Flockhart DA.Desta Z, et al.Clin Pharmacokinet. 2002;41(12):913-58. doi: 10.2165/00003088-200241120-00002.Clin Pharmacokinet. 2002.PMID:12222994Review.
Cited by
- Pharmacogenetic Expression of CYP2C19 in a Pediatric Population.Pierre-François MJD, Gagné V, Brukner I, Krajinovic M.Pierre-François MJD, et al.J Pers Med. 2022 Aug 26;12(9):1383. doi: 10.3390/jpm12091383.J Pers Med. 2022.PMID:36143168Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources